Recruiting nowNot applicable
Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans
Updated 2026-04-01 · NCT07506369See eligibility →
Sponsor
Clinical trials sponsored by University Hospital, Gentofte, Copenhagen
Active studies whose public registry record names University Hospital, Gentofte, Copenhagen as lead sponsor.
5active studies
2recruiting now
1countries represented
1largest site network
Current studies
Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.
Recruiting nowPhase 1, Phase 2
Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment
Updated 2025-09-18 · NCT07171723See eligibility →
Active, not recruitingNot applicable
Effects of Antagonizing the Ghrelin Receptor on Brain Food Cue Reactivity in Obesity
Updated 2026-04-29 · NCT06845033See eligibility →
Active, not recruitingNot applicable
Investigating Glucose Metabolism of LEAP2 With Total-body PET/CT
Updated 2025-06-19 · NCT06254365See eligibility →
Active, not recruitingPhase 2
Dapiglutide for the Treatment of Obesity
Updated 2024-12-05 · NCT05788601See eligibility →
Related sponsors
Novo Nordisk A/S71Eli Lilly and Company67University of Colorado, Denver36Cairo University31Mayo Clinic29Norwegian University of Science and Technology25
How current is this page?
The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.
Does appearing here mean I qualify?
No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.